Charming Medical Ltd income statement

In fiscal 2026, Charming Medical Ltd reported revenue of $4.8m, down 22.7% on the year before, operating income of −$29,237 (a -0.6% margin) and net income of −$22,648, or $0.00 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Charming Medical Ltd: income statement, annual
Fiscal year	2024Mar 2024	2025Mar 2025	2026Mar 2026
Revenue	6,015	6,222	4,808
Cost of revenue	11	16	35
Gross profit	6,004	6,206	4,772
Operating income	1,009	1,389	−29
Interest expense	26	21	16
Income before tax	1,003	1,435	133
Income tax	182	236	156
Net income	778	1,199	−23
Diluted EPS	$0.05	$0.08	$0.00
Diluted shares (average)	15m	15m	16m
EBITDA	1,401	1,652	187

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MCTA vs NRXS BMRA vs MCTA LUCD vs MCTA INBS vs MCTA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Charming Medical Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Charming Medical Ltd.